The study was conducted by the Global Vaccine Data Network on over 99 million people. Eight countries (Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland) were at the center of the project, and the results were published in the journal Vaccine.
Researchers’ Words (8/10)
« Most of those vaccinated were between 20 and 59 years old, and the highest number of doses were administered in France, » the researchers explained, specifying that the vaccines were from Pfizer, Moderna, and AstraZeneca. The results were not reassuring to medical staff, let alone patients.
Continue reading…
